Sprint Precision Technologies
688605
Jiangsu Jingxue Insulation Technology
301010
Global Infotech
300465
Hydsoft Technology
301316
SGSG Science&Technology
300561
CN Stock MarketDetailed Quotes
603235 JiangXi Tianxin Pharmaceutical
- 27.05
- +0.17+0.63%
Not Open Dec 12 15:00 CST
11.84BMarket Cap21.25P/E (TTM)
27.13High26.73Low13.64KlotVolume26.88Open26.88Pre Close36.79MTurnover0.93%Turnover Ratio24.89P/E (Static)437.78MShares32.0652wk High2.66P/B3.98BFloat Cap18.6352wk Low29.57Limit Up147.07MShs Float51.90Historical High24.19Limit Down1.49%Amplitude18.63Historical Low0.50Dividend TTM26.98Avg Price6.68KlotAsk1.85%Div YieldTTM100Lot Size6.41KlotBid
JiangXi Tianxin Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 8.49%1.61B | -4.81%1.07B | -14.46%494.5M | -18.34%1.88B | -15.02%1.49B | -9.73%1.12B | -4.61%578.12M | -8.63%2.3B | -0.48%1.75B | -2.05%1.24B |
| Operating revenue | 8.49%1.61B | -4.81%1.07B | -14.46%494.5M | -18.34%1.88B | -15.02%1.49B | -9.73%1.12B | -4.61%578.12M | -8.63%2.3B | -0.48%1.75B | -2.05%1.24B |
| Other operating revenue | ---- | -20.90%14.41M | ---- | -40.82%30.6M | ---- | -33.57%18.22M | ---- | -7.61%51.71M | ---- | 95.18%27.43M |
| Total operating cost | 1.35%1.06B | -9.95%671.17M | -27.47%329.54M | -17.19%1.36B | -9.82%1.04B | -7.65%745.33M | 9.86%454.33M | -2.79%1.64B | -0.37%1.16B | -0.11%807.08M |
| Operating cost | -1.08%931.58M | -12.49%618M | -25.16%296.34M | -19.71%1.16B | -10.78%941.71M | -2.58%706.2M | 11.93%395.95M | 1.07%1.45B | 7.12%1.06B | 5.30%724.9M |
| Operating tax surcharges | 4.35%15.94M | 3.48%10.07M | 25.85%5.14M | -9.84%19.81M | -3.37%15.28M | -5.49%9.73M | 28.86%4.09M | -3.53%21.97M | -6.32%15.81M | -15.95%10.29M |
| Operating expense | 8.33%24.63M | 7.59%17.04M | -44.25%3.09M | 7.05%32.86M | 5.58%22.74M | 15.56%15.84M | 12.46%5.54M | 10.03%30.7M | -2.33%21.53M | 2.36%13.71M |
| Administration expense | -4.79%98.97M | -8.27%58.41M | -14.01%27.93M | -5.43%136.35M | 1.25%103.94M | -0.78%63.68M | 3.64%32.48M | 28.40%144.18M | 31.81%102.66M | 25.29%64.18M |
| Financial expense | 16.24%-85.74M | 12.58%-77.41M | -12,866.80%-25.73M | -13.09%-102.43M | -3.88%-102.37M | -105.44%-88.55M | -95.80%201.56K | -349.82%-90.57M | -647.90%-98.54M | -335.52%-43.1M |
| -Interest expense (Financial expense) | ---- | 299.85%2.06M | ---- | -69.69%2.1M | ---- | -90.30%515.38K | ---- | -45.32%6.93M | ---- | -15.67%5.31M |
| -Interest Income (Financial expense) | ---- | -33.63%-44.31M | -99.07%-24.23M | -358.17%-74.46M | ---- | -4,465.15%-33.15M | -4,403.46%-12.17M | -274.53%-16.25M | ---- | 79.53%-726.25K |
| Research and development | 16.03%72.72M | 17.25%45.05M | 41.75%22.77M | 25.15%111.96M | 3.25%62.67M | 3.58%38.42M | 3.26%16.07M | 51.79%89.46M | 45.11%60.7M | 52.20%37.09M |
| Credit Impairment Loss | -129.49%-1.89M | -227.63%-2.64M | -344.43%-2.36M | -2.30%3.16M | 140.26%6.42M | 223.15%2.07M | 56.22%-530.47K | 145.98%3.23M | -28.59%2.67M | 59.86%-1.68M |
| Asset Impairment Loss | -472.13%-5.23M | -472.13%-5.23M | ---- | -197.36%-12.36M | 5.47%-914.33K | 5.47%-914.33K | ---- | -644.32%-4.16M | 79.89%-967.27K | -110.08%-967.27K |
| Other net revenue | -32.17%32.26M | 2.25%16.45M | 64.24%11.41M | -36.20%40.49M | -18.46%47.55M | -62.35%16.09M | -61.94%6.95M | 44.36%63.47M | 11.19%58.32M | 20.69%42.74M |
| Fair value change income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 200.00%4.33M | --4.33M | --4.33M |
| Invest income | 144.45%3.65M | -69.06%364.87K | 6.51%364.87K | -68.72%2.07M | -46.47%1.49M | 137.68%1.18M | -89.26%342.57K | 391.22%6.63M | -11.65%2.79M | -83.53%496.16K |
| -Including: Investment income associates | ---- | ---- | ---- | -299.01%-379.69K | ---- | ---- | ---269.56K | ---95.16K | ---- | ---- |
| Asset deal income | --962.33 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other revenue | -11.88%35.73M | 74.21%23.96M | 87.85%13.4M | -10.87%47.62M | -18.07%40.55M | -66.09%13.75M | -57.07%7.14M | -8.14%53.43M | -1.72%49.5M | 9.48%40.56M |
| Operating profit | 19.72%587.74M | 5.26%411.9M | 34.91%176.37M | -22.53%562.22M | -24.59%490.92M | -17.96%391.31M | -37.98%130.73M | -17.23%725.7M | 0.26%651M | -3.60%476.97M |
| Add:Non operating Income | 303.64%41.46K | 4,280.65%31.99K | --14.02K | 89.98%6.05M | -89.49%10.27K | -90.45%730.16 | ---- | 160.11%3.18M | 873.64%97.76K | 1.21%7.65K |
| Less:Non operating expense | 62.25%2.8M | 296.38%1.87M | 705.13%644.1K | -0.82%3.09M | -36.01%1.72M | -74.34%470.78K | -89.09%80K | -32.57%3.12M | 71.49%2.69M | 206.93%1.83M |
| Total profit | 19.58%584.98M | 4.92%410.06M | 34.51%175.74M | -22.13%565.17M | -24.55%489.21M | -17.74%390.84M | -37.80%130.65M | -16.90%725.76M | 0.10%648.4M | -3.85%475.14M |
| Less:Income tax cost | 18.60%90.5M | 6.59%64.9M | 27.82%28.19M | -13.82%89.32M | -21.51%76.31M | -17.60%60.88M | -30.90%22.05M | -19.96%103.64M | -3.88%97.22M | -0.76%73.89M |
| Net profit | 19.76%494.48M | 4.61%345.17M | 35.87%147.55M | -23.51%475.85M | -25.09%412.9M | -17.77%329.96M | -39.04%108.6M | -16.37%622.12M | 0.84%551.18M | -4.40%401.25M |
| Net profit from continuing operation | 19.76%494.48M | 4.61%345.17M | 35.87%147.55M | -23.51%475.85M | -25.09%412.9M | -17.77%329.96M | -39.04%108.6M | -16.37%622.12M | 0.84%551.18M | -4.40%401.25M |
| Net profit of parent company owners | 19.76%494.48M | 4.61%345.17M | 35.87%147.55M | -23.51%475.85M | -25.09%412.9M | -17.77%329.96M | -39.04%108.6M | -16.37%622.12M | 0.84%551.18M | -4.40%401.25M |
| Earning per share | ||||||||||
| Basic earning per share | 20.21%1.13 | 5.33%0.79 | 36.00%0.34 | -27.81%1.09 | -31.39%0.94 | -26.47%0.75 | -44.44%0.25 | -20.11%1.51 | -1.44%1.37 | -4.67%1.02 |
| Diluted earning per share | 20.21%1.13 | 5.33%0.79 | 36.00%0.34 | -27.81%1.09 | -31.39%0.94 | -26.47%0.75 | -44.44%0.25 | -20.11%1.51 | -1.44%1.37 | -4.67%1.02 |
| Other composite income | ||||||||||
| Total composite income | 19.76%494.48M | 4.61%345.17M | 35.87%147.55M | -23.51%475.85M | -25.09%412.9M | -17.77%329.96M | -39.04%108.6M | -16.37%622.12M | 0.84%551.18M | -4.40%401.25M |
| Total composite income of parent company owners | 19.76%494.48M | 4.61%345.17M | 35.87%147.55M | -23.51%475.85M | -25.09%412.9M | -17.77%329.96M | -39.04%108.6M | -16.37%622.12M | 0.84%551.18M | -4.40%401.25M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Zhonghui Certified Public Accountants (Special General Partnership) | -- | -- | -- | Zhonghui Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
